ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
1-Year Return
4.95%
This Quarter Return
+4.42%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$231M
AUM Growth
-$37.1M
(-14%)
Cap. Flow
-$49.7M
Cap. Flow
% of AUM
-21.54%
Top 10 Holdings %
Top 10 Hldgs %
50.4%
Holding
85
New
16
Increased
17
Reduced
31
Closed
20
Top Buys
| 1 |
Cigna
CI
|
$7.45M |
| 2 |
Merck
MRK
|
$5.18M |
| 3 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$3.48M |
| 4 |
Baxter International
BAX
|
$3.46M |
| 5 |
IQVIA
IQV
|
$3.29M |
Top Sells
| 1 |
Boston Scientific
BSX
|
$10.3M |
| 2 |
Becton Dickinson
BDX
|
$7.7M |
| 3 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$7.18M |
| 4 |
UnitedHealth
UNH
|
$7M |
| 5 |
Johnson & Johnson
JNJ
|
$6.73M |
Sector Composition
| 1 | Healthcare | 93.59% |
| 2 | Financials | 2.32% |
| 3 | Real Estate | 0.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Thermo Fisher Scientific
TMO
$183B
| $706K | 0.31% |
3,407
-20,401
| -86% | -$4.23M |
|
52
Standard BioTools
LAB
$477M
| $680K | 0.29% |
+114,110
| New | +$680K |
|
|
IMGN
53
DELISTED
Immunogen Inc
IMGN
| $664K | 0.29% |
+68,265
| New | +$664K |
|
54
Viking Therapeutics
VKTX
$2.93B
| $574K | 0.25% |
60,499
-58,601
| -49% | -$556K |
|
|
BLCM
55
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $530K | 0.23% |
7,180
-7,250
| -50% | -$535K |
|
56
Pediatrix Medical
MD
$1.46B
| $409K | 0.18% |
9,442
-64,775
| -87% | -$2.81M |
|
57
Nektar Therapeutics
NKTR
$630M
| $386K | 0.17% |
+527
| New | +$386K |
|
|
AKTX
58
Akari Therapeutics
AKTX
$23.2M
| $352K | 0.15% |
9,015
-860
| -9% | -$33.6K |
|
59
Heron Therapeutics
HRTX
$195M
| $343K | 0.15% |
+8,824
| New | +$343K |
|
60
Cencora
COR
$57.1B
| $315K | 0.14% |
+3,692
| New | +$315K |
|
61
Clearside Biomedical
CLSD
$26.7M
| $314K | 0.14% |
+29,400
| New | +$314K |
|
|
ZGNX
62
DELISTED
Zogenix, Inc.
ZGNX
| $286K | 0.12% |
6,473
-9,827
| -60% | -$434K |
|
63
Labcorp
LH
$22.7B
| $224K | 0.1% |
1,454
-32,971
| -96% | -$5.08M |
|
64
Ocugen
OCGN
$319M
| $140K | 0.06% |
+936
| New | +$140K |
|
|
RNTX
65
Rein Therapeutics, Inc. Common Stock
RNTX
$31.3M
| – | – |
-3,785
| Closed | -$615K |
|
66
AnaptysBio
ANAB
$604M
| – | – |
-3,130
| Closed | -$326K |
|
|
AVDL
67
Avadel Pharmaceuticals
AVDL
$1.43B
| – | – |
-55,700
| Closed | -$406K |
|
68
Cardinal Health
CAH
$35.6B
| – | – |
-22,542
| Closed | -$1.41M |
|
69
Quest Diagnostics
DGX
$20.2B
| – | – |
-13,000
| Closed | -$1.3M |
|
70
Danaher
DHR
$141B
| – | – |
-23,987
| Closed | -$2.08M |
|
71
Icon
ICLR
$13.7B
| – | – |
-8,400
| Closed | -$992K |
|
72
Incyte
INCY
$16.8B
| – | – |
-19,420
| Closed | -$1.62M |
|
73
Jazz Pharmaceuticals
JAZZ
$7.79B
| – | – |
-5,100
| Closed | -$770K |
|
74
Masimo
MASI
$7.73B
| – | – |
-20,900
| Closed | -$1.84M |
|
75
VanEck Pharmaceutical ETF
PPH
$621M
| – | – |
-25,500
| Closed | -$1.45M |
|